Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial (Q38009430)
Jump to navigation
Jump to search
scientific article published on 11 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial |
scientific article published on 11 May 2012 |
Statements
1 reference
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial (English)
1 reference
IVAN Study Investigators
1 reference
Usha Chakravarthy
1 reference
Simon P Harding
1 reference
Chris A Rogers
1 reference
Susan M Downes
1 reference
Andrew J Lotery
1 reference
Sarah Wordsworth
1 reference
Barnaby C Reeves
1 reference
1 reference